Asston Pharmaceuticals IPO Sees 26x Subscription on Final Day, GMP at 24%

Asston Pharmaceuticals' IPO has been subscribed 26.68 times, with bids for 38.04 million shares against the 1.6 million shares on offer. The SME offering has received bids from retail and non-institutional investors, with the qualified institutional buyers' portion subscribed 7.98 times. The unlisted shares are trading at ₹153, commanding a 24.39% premium compared to the upper end of the price band. The company plans to raise ₹27.56 crore through a fresh issue of 2.24 million equity shares.

Asston Pharmaceuticals' initial public offering (IPO) has received an overwhelming response from investors, with bids for 38.04 million shares against the 1.6 million shares on offer. The SME offering, which opened on Wednesday, July 9, has been subscribed 26.68 times, according to data from the BSE [3].

The demand for Asston Pharmaceuticals' shares was driven primarily by retail and non-institutional investors (NIIs). The retail investors' portion was subscribed 33.10 times, while the NIIs' portion was subscribed 33.7 times. The qualified institutional buyers (QIBs) portion was subscribed 7.98 times [3].

The unlisted shares of Asston Pharmaceuticals are currently trading at ₹153 in the grey market, commanding a premium of ₹30 or 24.39% over the upper end of the price band of ₹115 to ₹123 [3].

Asston Pharmaceuticals plans to raise ₹27.56 crore through a fresh issue of 2.24 million equity shares. The funds will be used for acquiring machinery in the manufacturing unit, meeting working capital requirements, repaying debt, and general corporate purposes [1].

The IPO, which opened for subscription on Wednesday, July 9, will close today, July 11, 2025. The basis of allotment is expected to be finalized on Monday, July 14, 2025, with shares scheduled to be listed on the BSE SME platform tentatively on Wednesday, July 16, 2025 [1, 2, 3].

References:
[1] https://m.economictimes.com/markets/ipos/fpos/asston-pharmaceuticals-ipo-opens-for-subscription-with-decent-gmp-check-details/articleshow/122331266.cms
[2] https://www.business-standard.com/markets/news/retail-investors-drive-demand-for-asston-pharmaceuticals-ipo-gmp-at-24-125071000511_1.html
[3] https://www.business-standard.com/markets/news/asston-pharmaceuticals-ipo-closes-today-subscription-rises-26x-gmp-at-24-125071100364_1.html